Live Breaking News & Updates on Jort vijverberg

Stay informed with the latest breaking news from Jort vijverberg on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jort vijverberg and stay connected to the pulse of your community

Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's disease

PURCHASE - Cognition Therapeutics, Inc., , a clinical stage company developing drugs that treat neurodegenerative disorders, provided a recap of the virtual KOL event hosted on April 12, 2024...

Amsterdam , Noord-holland , Netherlands , Anton-porsteinsson , Jort-vijverberg , Mike-moyer , Casey-mcdonald , Martinj-sadowski , Lisa-ricciardi , Company-or-cognition , Securities-exchange-commission , Cognition-therapeutics-inc

Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer's Disease on April 12, 2024 -April 01, 2024 at 07:31 am EDT

NEW YORK, April 01, 2024 -- Cognition Therapeutics, Inc. , a clinical stage company developing drugs that treat neurodegenerative disorders, today announced it will host a virtual KOL event on...

United-states , Amsterdam , Noord-holland , Netherlands , Poland , Iceland , American , Casey-mcdonald , Anton-porsteinsson , Martinj-sadowski , Mike-moyer , Jort-vijverberg

Cognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer's Disease at CTAD

PURCHASE, N.Y., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) announced that Willem de Haan, M.D., Ph.D., a neurologist and senior researcher at the Amsterdam University Medical Centers’ Alzheimer Center, is presenting complete EEG findings from the Phase 2 SEQUEL study at the Clinical Trials on Alzheimer’s Disease (CTAD) conference. SEQUEL was conducted at the Amsterdam UMC in the Netherlands with Everard (Jort) Vijverberg, M.D.,

Amsterdam , Noord-holland , Netherlands , Casey-mcdonald , Jort-vijverberg , Daniel-kontoh-boateng , Nasdaq , Cognition-therapeutics-inc , Company-or-cognition , Tiberend-strategic-advisors-inc , National-institutes-of-health , National-institute-of-aging

Cognition Therapeutics (CGTX) Reports Positive Topline Results for CT1812 Phase 2 SEQUEL Study

Cognition Therapeutics (CGTX) Reports Positive Topline Results for CT1812 Phase 2 SEQUEL Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Netherlands , Amsterdam , Noord-holland , Lisa-ricciardi , Anthony-caggiano , Daniel-kontoh-boateng , Jort-vijverberg , Aline-sherwood , Securities-exchange-commission , Amsterdam-university-medical-center-alzheimer , Scienta-communications , Nasdaq

Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer's Disease

Results Show Positive Treatment Effect of CT1812 on Global and Regional Brain Activity Management Holding Webcast Conference Call at 8:00am ET Today NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-st...

Netherlands , Amsterdam , Noord-holland , Daniel-kontoh-boateng , Aline-sherwood , Anthony-caggiano , Lisa-ricciardi , Jort-vijverberg , National-institute-on-aging , Amsterdam-university-medical-centers , Cognition-therapeutics-inc , Globenewswire-inc

Cognition Therapeutics Awarded $2.14 Million in Supplemental Grant Funding from NIA to Support SEQUEL Clinical Trial

27.09.2022 - PURCHASE, N.Y., Sept. 27, 2022 (GLOBE NEWSWIRE) - Cognition Therapeutics, Inc. (Nasdaq: CGTX) announced today that the company has received a $2.14M grant award from the National Institute on Aging (NIA), a division of the National Institutes of ... Seite 1

Amsterdam , Noord-holland , Netherlands , Lisa-ricciardi , Jort-vijverberg , Neurology-alzheimer-center , National-institutes-of-health , Cognition-therapeutics-inc , Brain-research-center , National-institute-on-aging , Nasdaq , National-institute